About Cardea Sciences

About company

Cardea Sciences develops a novel, non-invasive heart monitoring device to improve treatment and quality of life of Atrial Fibrillation patients. Cardea Sciences join in a research collaboration with Samsung Strategy and Innovation Center. They also have partners like the Entrepreneurship Lab, NYCEDC, Mount Sinai, and NIH. Cardea Sciences was founded by Dr. Ya-El Mandel-Portnoy in 2016.